Prague/Norwood – The international clinical trial company Medpace Inc. (Norwood, USA) has acquired the Czech contract research organisation Monax s.r.o. (Prague) for an undisclosed sum. With the acquisition, which the firm announced at the end of August, Medpace hopes to strengthen its presence in Europe. Monax’s founder, Dr. Petr Potuznik, will continue to lead Medpace’s clinical operations for the Czech Republic and Slovakia, according to the company. The 500-employee enterprise, which announced its intention to go public in 2009 according to Business Courier, had revenues of US$59.5 million in 2006.